During the past decade, Centre Hospitalier de Digne les Bains conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Digne les Bains" are "Colorectal Cancer" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Centre Hospitalier de Digne les Bains" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Digne les Bains" are "Drug" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (1 trials), "erlotinib hydrochloride" (1 trials), "fluorouracil" (1 trials), "gemcitabine hydrochloride" (1 trials) and "irinotecan hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Digne les Bains" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Digne les Bains". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centre Hospitalier de Digne les Bains, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Digne les Bains, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".